147 related articles for article (PubMed ID: 38858189)
1. [Discussion on the prevention and control strategies of chronic hepatitis B: experience from AIDS prevention and control in China].
Li J; Liu ZF
Zhonghua Gan Zang Bing Za Zhi; 2024 May; 32(5):402-405. PubMed ID: 38858189
[TBL] [Abstract][Full Text] [Related]
2. [Cost-effectiveness of community-based treatment of chronic hepatitis B in China].
Zhang SX; Yang PC; Cai YL; Lin Y; Zou YH
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):860-867. PubMed ID: 28738456
[No Abstract] [Full Text] [Related]
3. [Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)].
;
Zhonghua Gan Zang Bing Za Zhi; 2022 Dec; 30(12):1309-1331. PubMed ID: 36891718
[TBL] [Abstract][Full Text] [Related]
4. How to control highly endemic hepatitis B in Asia.
Shan S; Cui F; Jia J
Liver Int; 2018 Feb; 38 Suppl 1():122-125. PubMed ID: 29427490
[TBL] [Abstract][Full Text] [Related]
5. Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in China.
Yu R; Fan R; Hou J
Front Med; 2014 Jun; 8(2):135-44. PubMed ID: 24810645
[TBL] [Abstract][Full Text] [Related]
6. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
Zhao S; Xu Z; Lu Y
Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354
[TBL] [Abstract][Full Text] [Related]
7. [Development of Markov models for economics evaluation of strategies on hepatitis B vaccination and population-based antiviral treatment in China].
Yang PC; Zhang SX; Sun PP; Cai YL; Lin Y; Zou YH
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):845-851. PubMed ID: 28738454
[No Abstract] [Full Text] [Related]
8. [Epidemiologic characteristics and strategies on prevention and control of sexually transmitted human immunodeficiency virus/acquired immunodeficiency syndrome in China].
Li Y; Lin ZM; Xie YQ; Lin P
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Dec; 52(12):1309-1314. PubMed ID: 30522239
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive approach to controlling chronic hepatitis B in China.
Shan S; Zhao X; Jia J
Clin Mol Hepatol; 2024 Apr; 30(2):135-143. PubMed ID: 38176692
[TBL] [Abstract][Full Text] [Related]
10. Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.
Nayagam S; Chan P; Zhao K; Sicuri E; Wang X; Jia J; Wei L; Walsh N; Rodewald LE; Zhang G; Ailing W; Zhang L; Chang JH; Hou W; Qiu Y; Sui B; Xiao Y; Zhuang H; Thursz MR; Scano F; Low-Beer D; Schwartländer B; Wang Y; Hallett TB
Clin Infect Dis; 2021 Mar; 72(5):743-752. PubMed ID: 32255486
[TBL] [Abstract][Full Text] [Related]
11. [Study on knowledge, attitudes and behaviors regarding infectious diseases among Chinese people in 2002].
Ma JM; Liu N; Chen AP; Yang GH
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jun; 26(6):389-93. PubMed ID: 16185442
[TBL] [Abstract][Full Text] [Related]
12. [The guidelines of prevention and treatment for chronic hepatitis B (2019 version)].
;
Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):938-961. PubMed ID: 31941257
[TBL] [Abstract][Full Text] [Related]
13. Prevention of perinatal hepatitis B transmission in Haimen City, China: Results of a community public health initiative.
Evans AA; Cohen C; Huang P; Qian L; London WT; Block JM; Chen G
Vaccine; 2015 Jun; 33(26):3010-5. PubMed ID: 25698491
[TBL] [Abstract][Full Text] [Related]
14. Elimination of hepatitis B virus infection in children: experience and challenge in China.
Tang J; Luo YQ; Zhou YH
Chin Med J (Engl); 2021 Oct; 134(23):2818-2824. PubMed ID: 34636773
[TBL] [Abstract][Full Text] [Related]
15. Management Algorithm for Interrupting Mother-to-Child Transmission of Hepatitis B Virus.
Hou J; Cui F; Ding Y; Dou X; Duan Z; Han G; Jia J; Mao Q; Li J; Li Z; Liu Z; Wei L; Xie Q; Yang X; Zhang H; Zhuang H
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):1929-1936.e1. PubMed ID: 30312789
[TBL] [Abstract][Full Text] [Related]
16. Impact of the national hepatitis B immunization program in China: a modeling study.
Liu Z; Li M; Hutton DW; Wagner AL; Yao Y; Zhu W; Cao L; Tang S; Pan J; Wang Y; Zhao Q; Ren H; Wang Y; Wang W
Infect Dis Poverty; 2022 Oct; 11(1):106. PubMed ID: 36221140
[TBL] [Abstract][Full Text] [Related]
17. [Progress and challenges in achieving the WHO goal on 'Elimination of Hepatitis B by 2030' in China].
Liu J; Liu M
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jun; 40(6):605-609. PubMed ID: 31238605
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B control in the World Health Organization's Western Pacific Region: targets, strategies, status.
Hennessey K; Mendoza-Aldana J; Bayutas B; Lorenzo-Mariano KM; Diorditsa S
Vaccine; 2013 Dec; 31 Suppl 9():J85-92. PubMed ID: 24331026
[TBL] [Abstract][Full Text] [Related]
19. The epidemic of major sexually transmitted diseases in Shanghai, China, 2009-2018.
Tang Q; Zhang X; Lu H
Biosci Trends; 2019; 13(3):273-275. PubMed ID: 31327795
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
